The FDA is currently studying psilocybin therapy aimed at treating chronic low back pain

The FDA is currently reviewing studies for psilocybin therapy aimed at treating chronic low back pain, with clinical trials being conducted to evaluate its effectiveness. This could represent a significant step in the use of psychedelics for pain management.

It is expected psychedelics, MDMA and LSD will also prove effective in the treatment of certain mental health issues, including PTSD, severe depression, and suicidal ideation. U.S. veterans have reported benefiting from these drugs after traveling to clinics in Mexico that administer it.
 
Back
Top